News - Page 706

TLDR: – Investment firms are raising billions of dollars to buy discounted stakes in venture capital-backed technology start-ups. – The start-up secondary market, where investors and employees buy and sell shares in

TLDR: Las Olas Venture Capital (LOVC) has made a seed investment in Trajektory, a B2B SaaS platform that provides data analytics for sports sponsorships. Trajektory aggregates and analyzes sponsorship data from multiple

TLDR: After the recent announcement of Apple’s Digital Health Initiative, concerns have been raised about the addictive nature of smartphones and the impact on mental well-being, particularly among young people. The initiative

TLDR: Foley Hoag has expanded its emerging company and venture capital team in Denver with the addition of partners Rose Standifer and Allie Clark. Standifer specializes in advising emerging companies on various

TLDR: Executives from Harvard’s $51 billion endowment visited Silicon Valley last week in an effort to repair relationships with investors. The team from Harvard Management Company visited firms such as Sequoia Capital,

Act One Ventures, a Los Angeles-based venture capital firm, has raised $73 million for its third fund, bringing its assets under management to $148 million. This comes at a time when the

TLDR: Investing in alcohol has the potential for substantial growth and diversification of portfolios. Key investment strategies include alcohol stocks, private equity, mutual funds, collectibles, and craft breweries and distilleries. Today marks

Raj Prabhu, CEO of clean energy communications and consulting firm Mercom Capital Group, announced that solar companies raised $34.3 billion in corporate funding in 2023, the highest amount raised in over a

TLDR: Join a webinar to learn about raising seed funding for startups Topics covered include legal structure, funding stages, convertible debt and SAFEs Also discussed are pro forma cap tables, venture financing,

TLDR: Deerfield Management is partnering with Washington University to launch a new R&D venture called VeritaScience. The partnership will focus on the discovery, clinical development, and commercialization of therapeutic and diagnostic candidates.